These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37802037)

  • 1. Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19.
    Kawakami E; Saiki N; Yoneyama Y; Moriya C; Maezawa M; Kawamura S; Kinebuchi A; Kono T; Funata M; Sakoda A; Kondo S; Ebihara T; Matsumoto H; Togami Y; Ogura H; Sugihara F; Okuzaki D; Kojima T; Deguchi S; Vallee S; McQuade S; Islam R; Natarajan M; Ishigaki H; Nakayama M; Nguyen CT; Kitagawa Y; Wu Y; Mori K; Hishiki T; Takasaki T; Itoh Y; Takayama K; Nio Y; Takebe T
    Cell Stem Cell; 2023 Oct; 30(10):1315-1330.e10. PubMed ID: 37802037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.
    Joffre J; Rodriguez L; Matthay ZA; Lloyd E; Fields AT; Bainton RJ; Kurien P; Sil A; Calfee CS; Woodruff PG; Erle DJ; Hendrickson C; Krummel MF; Langelier CR; Matthay MA; Kornblith LZ; Hellman J; ;
    Am J Respir Crit Care Med; 2022 Oct; 206(8):961-972. PubMed ID: 35649173
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.
    Chang JC
    Vasc Health Risk Manag; 2021; 17():273-298. PubMed ID: 34103921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.
    Yu J; Yuan X; Chen H; Chaturvedi S; Braunstein EM; Brodsky RA
    Blood; 2020 Oct; 136(18):2080-2089. PubMed ID: 32877502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.
    Zhang H; Gerasimovskaya E; McCarthy MK; May NA; Prasad RR; Riddle S; McKeon BA; Kumar S; Li M; Hu CJ; Frid MG; Morrison TE; Stenmark KR
    Am J Respir Cell Mol Biol; 2023 Aug; 69(2):210-219. PubMed ID: 37071849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.
    Perico L; Morigi M; Galbusera M; Pezzotta A; Gastoldi S; Imberti B; Perna A; Ruggenenti P; Donadelli R; Benigni A; Remuzzi G
    Front Immunol; 2022; 13():827146. PubMed ID: 35320941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Activation
    Niederreiter J; Eck C; Ries T; Hartmann A; Märkl B; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2022; 13():835156. PubMed ID: 35237273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement contributions to COVID-19.
    Conway EM; Pryzdial ELG
    Curr Opin Hematol; 2022 Sep; 29(5):259-265. PubMed ID: 35852851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
    Gando S; Wada T
    Front Immunol; 2021; 12():649122. PubMed ID: 34177896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
    Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
    Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovascular injury with complement activation and inflammation in COVID-19.
    Lee MH; Perl DP; Steiner J; Pasternack N; Li W; Maric D; Safavi F; Horkayne-Szakaly I; Jones R; Stram MN; Moncur JT; Hefti M; Folkerth RD; Nath A
    Brain; 2022 Jul; 145(7):2555-2568. PubMed ID: 35788639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 associated coagulopathy: Mechanisms and host-directed treatment.
    Plášek J; Gumulec J; Máca J; Škarda J; Procházka V; Grézl T; Václavík J
    Am J Med Sci; 2022 Jun; 363(6):465-475. PubMed ID: 34752741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation.
    Wang Z; Zhang Z; Li Y; Zhang Y; Wei M; Li H; Yang S; Zhou Y; Zhou X; Xing G
    Hypertens Res; 2023 Jul; 46(7):1759-1770. PubMed ID: 37188751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019.
    Magro CM; Mulvey JJ; Laurence J; Seshan S; Crowson AN; Dannenberg AJ; Salvatore S; Harp J; Nuovo GJ
    Hum Pathol; 2020 Dec; 106():106-116. PubMed ID: 33058948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.